Drug Database
Back to search

France· FR:66545656

CIBINQO 50 mg, comprimé pelliculé

A abrocitinib product containing abrocitinib, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC D11AH08

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCIBINQO 50 mg, comprimé pelliculéATCD11AH08REGISTER NO.FR:66545656PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about abrocitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Abrocitinib is registered in 15 of 19 countries.

Countries holding a registration under ATC D11AH08 (abrocitinib), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search abrocitinib products by name

Abrocitinib · ATC D11AH08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abrocitinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.26 in France to $295.64 in United States — a ×1143 gap.

  • France: $0.26 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Abrocitinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • US United States$295.64 (acquisition cost)
  • CH Switzerland$122.11
  • FR France$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ABROCITINIB
Manufacturer
PFIZER EUROPE MA EEIG (BELGIQUE)
Country
France (FR)
ATC code
D11AH08
ATC class
Abrocitinib
Defined daily dose
0.15 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930242575
    4 plaquette(s) PVDC aluminium de 7 comprimé(s)
    EUR 1.06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Abrocitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abrocitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cibinqo
  • Liechtenstein · Cibinqo
  • Norway · Cibinqo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fb90c3c-795c-45d4-b004-499bcbcaed78
GET /v1/drugs/3fb90c3c-795c-45d4-b004-499bcbcaed78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66545656",
  "date_amm": "2021-12-09",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/21/1593",
  "substance": "ABROCITINIB",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about abrocitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console